|
Cost analysis of bivalirudin versus reference anticoagulants without GP IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention for acute coronary syndrome in routine clinical practice. Pompidou registry |
Puymirat E, Cohen S, Vedrenne G, Caruba T, Sabatier B, Danchin N, Durand E |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Puymirat E, Cohen S, Vedrenne G, Caruba T, Sabatier B, Danchin N, Durand E. Cost analysis of bivalirudin versus reference anticoagulants without GP IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention for acute coronary syndrome in routine clinical practice. Pompidou registry. Annales de Cardiologie et d'Angeiologie 2013; 62(2): 89-94 Indexing Status Subject indexing assigned by NLM MeSH Acute Coronary Syndrome /economics /therapy; Aged; Aged, 80 and over; Anticoagulants /economics; Antithrombins /economics /therapeutic use; Cost-Benefit Analysis; Drug Costs; Female; Heparin /economics; Hirudins /economics; Hospitals, University; Humans; Length of Stay /economics; Male; Middle Aged; Paris; Peptide Fragments /economics /therapeutic use; Percutaneous Coronary Intervention; Platelet Glycoprotein GPIIb-IIIa Complex /antagonists & Prospective Studies; Recombinant Proteins /economics /therapeutic use; Registries; Treatment Outcome; inhibitors AccessionNumber 22013020964 Date bibliographic record published 10/06/2013 |
|
|
|